cabergoline

As nouns the difference between cabergoline and bromocriptine

is that cabergoline is a potent dopamine receptor agonist, used in the treatment of parkinson's disease while bromocriptine is an ergoline derivative and dopamine agonist used in the treatment of pituitary tumours and parkinson's disease.

Lysergamide is a hypernym of cabergoline.

As nouns the difference between lysergamide and cabergoline

is that lysergamide is (chemistry) any amide of lysergic acid while cabergoline is a potent dopamine receptor agonist, used in the treatment of parkinson's disease.

Ergoline is a hypernym of cabergoline.

As nouns the difference between ergoline and cabergoline

is that ergoline is (chemistry) a tetracyclic heterocycle whose structural skeleton is contained in a diverse range of alkaloids, including some psychedelic drugs, and whose derivatives are used clinically for vasoconstriction and in the treatment of migraine and parkinson's disease while cabergoline is a potent dopamine receptor agonist, used in the treatment of parkinson's disease.

As nouns the difference between agonist and cabergoline

is that agonist is someone involved in a contest or battle (as in an agon) while cabergoline is a potent dopamine receptor agonist, used in the treatment of parkinson's disease.

As nouns the difference between dopamine and cabergoline

is that dopamine is (label) a neurotransmitter associated with movement, attention, learning, and the brain’s pleasure and reward system while cabergoline is a potent dopamine receptor agonist, used in the treatment of parkinson's disease.